Klaus Giese
Directeur Général chez Pantherna Therapeutics GmbH
Profil
Klaus Giese is currently the Managing Director at Pantherna Therapeutics GmbH and the Chief Scientific Officer at Atugen AG.
Previously, he worked as a Group Leader at Chiron Corp.
from 1994 to 1998 and as the Chief Scientific Officer at Silence Therapeutics Plc from 1999 to 2013.
He also held positions as a Research Scientist at the Howard Hughes Medical Institute, Inc. and the Max-Planck-Institute for Molecular Genetics.
Dr. Giese obtained his undergraduate and doctorate degrees from Freie Universität Berlin.
Postes actifs de Klaus Giese
| Sociétés | Poste | Début |
|---|---|---|
Atugen AG
 Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Directeur Technique/Scientifique/R&D | 01/01/1999 |
Pantherna Therapeutics GmbH
 Pantherna Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Pantherna Therapeutics GmbH enages in developing of therapeutics for vascular diseases. The company is headquartered in Hennigsdorf, Germany. | Directeur Général | 01/01/2017 |
Anciens postes connus de Klaus Giese
| Sociétés | Poste | Fin |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Directeur Technique/Scientifique/R&D | 18/11/2013 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 01/01/1998 |
| Max-Planck-Institute for Molecular Genetics | Directeur Technique/Scientifique/R&D | - |
Howard Hughes Medical Institute, Inc.
 Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD. | Directeur Technique/Scientifique/R&D | - |
Formation de Klaus Giese
| Freie Universität Berlin | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SILENCE THERAPEUTICS PLC | Commercial Services |
| Entreprise privées | 4 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Howard Hughes Medical Institute, Inc.
Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD. | Miscellaneous |
Atugen AG
Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Health Technology |
Pantherna Therapeutics GmbH
Pantherna Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Pantherna Therapeutics GmbH enages in developing of therapeutics for vascular diseases. The company is headquartered in Hennigsdorf, Germany. | Health Technology |